ProCE Banner Activity

Premium Education

CE / CME

Medical Cannabis: What It Is, What It’s Not, and Which Symptoms Does It Treat?

Video

Julia Arnsten, MD, MPH, from Albert Einstein College of Medicine, leads an in-depth exploration of current research and evolving policies on medical cannabis in the United States. This course presents evidence-based insights on the role of cannabis in managing chronic pain, its potential effects on opioid use and overdose rates, and strategies for effective patient communication. The content focuses on education, aiming to inform healthcare professionals about the scientific findings and clinical considerations.

Additional premium programming can be found in our course catalog. Be sure to check back frequently, as we continue to update this catalog with new programs!  

Nurses: 1.00 Nursing contact hour

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Released: November 04, 2024

Expiration: November 03, 2027

Course Fee

$50.00

Share

Faculty

Julia Arnsten

Julia Arnsten, MD, MPH

Professor of Medicine, Psychiatry, Epidemiology
Division Chief, General Internal Medicine
Department of Medicine
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, New York

Target Audience

This program is intended for physicians, nursing professionals, and pharmacists.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of learners regarding medical cannabis.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Review current laws for cannabis use in the United States

  • Outline the function of the endocannabinoid system

  • Evaluate the risks and benefits of medical cannabis use based on clinical trials

  • Develop strategies to manage cannabis use topics professionally and thoughtfully in clinical practice

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Julia Arnsten, MD, MPH

Professor of Medicine, Psychiatry, Epidemiology
Division Chief, General Internal Medicine
Department of Medicine
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, New York

Julia Arnsten, MD, MPH, has no relevant financial relationships to disclose.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from November 04, 2024, through November 03, 2027:

  1. Login or Sign Up for an account by clicking at the top of this page.

  2. Read the target audience, learning objectives, and faculty disclosures.

  3. View and study the content in its entirety.

  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-24-310-H99-P 

Type of Activity: Application

Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.